Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Els Brouwers

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Drug Testing and Analysis|March 19, 2016
Validation of a sample pretreatment protocol to convert a drug-sensitive into a drug-tolerant anti-infliximab antibody immunoassayThomas Van Stappen, Els Brouwers, Séverine Vermeire, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 5, 2016
Characterization and Application of a Unique Panel of Monoclonal Antibodies Generated against EtanerceptIris Detrez, Els Brouwers, Miet Peeters, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 13, 2005
Development of ELISAs measuring the extent of TAFI activationErik Ceresa, Els Brouwers, Miet Peeters, et al.
Inflammatory Bowel Diseases|August 19, 2015
An Optimized Anti-infliximab Bridging Enzyme-linked Immunosorbent Assay for Harmonization of Anti-infliximab Antibody Titers in Patients with Inflammatory Bowel DiseasesThomas Van Stappen, Thomas Billiet, Niels Vande Casteele, et al.
Therapeutic Drug Monitoring|December 20, 2014
Generation of a Highly Specific Monoclonal Anti-Infliximab Antibody for Harmonization of TNF-Coated Infliximab AssaysThomas Van Stappen, Els Brouwers, Sophie Tops, et al.
Thrombosis Research|March 12, 2011
Characterization of a panel of monoclonal antibodies toward mouse PAI-1 that exert a significant profibrinolytic effect in vivoBritt Van De Craen, Ilse Scroyen, Rana Abdelnabi, et al.
Clinical and Experimental Dermatology|March 4, 2022
Therapeutic drug monitoring in dermatology: the way towards dose optimization of secukinumab in chronic plaque psoriasisRani Soenen, Zhigang Wang, Lynda Grine, et al.
Journal of Immunological Methods|August 19, 2009
Development and evaluation of monoclonal antibodies as probes to assess the differences between two tomato pectin methylesterase isoenzymesEvelien Vandevenne, Sandy Van Buggenhout, Thomas Duvetter, et al.
Journal of Pharmaceutical and Biomedical Analysis|July 3, 2020
Development and validation of immunoassays for monitoring of guselkumab and anti-guselkumab antibodies in patients with moderate-to-severe psoriasisNathalie Van den Berghe, Aurélie Truffot, Miet Peeters, et al.
Research and Practice in Thrombosis and Haemostasis|July 22, 2022
Novel ELISA for the specific detection of protease NEXIN-1 in human biological samplesLaurence Venisse, Déborah François, Célina Madjène, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Drug Testing and Analysis|March 19, 2016
Validation of a sample pretreatment protocol to convert a drug-sensitive into a drug-tolerant anti-infliximab antibody immunoassayThomas Van Stappen, Els Brouwers, Séverine Vermeire, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 5, 2016
Characterization and Application of a Unique Panel of Monoclonal Antibodies Generated against EtanerceptIris Detrez, Els Brouwers, Miet Peeters, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 13, 2005
Development of ELISAs measuring the extent of TAFI activationErik Ceresa, Els Brouwers, Miet Peeters, et al.
Inflammatory Bowel Diseases|August 19, 2015
An Optimized Anti-infliximab Bridging Enzyme-linked Immunosorbent Assay for Harmonization of Anti-infliximab Antibody Titers in Patients with Inflammatory Bowel DiseasesThomas Van Stappen, Thomas Billiet, Niels Vande Casteele, et al.
Therapeutic Drug Monitoring|December 20, 2014
Generation of a Highly Specific Monoclonal Anti-Infliximab Antibody for Harmonization of TNF-Coated Infliximab AssaysThomas Van Stappen, Els Brouwers, Sophie Tops, et al.
Thrombosis Research|March 12, 2011
Characterization of a panel of monoclonal antibodies toward mouse PAI-1 that exert a significant profibrinolytic effect in vivoBritt Van De Craen, Ilse Scroyen, Rana Abdelnabi, et al.
Clinical and Experimental Dermatology|March 4, 2022
Therapeutic drug monitoring in dermatology: the way towards dose optimization of secukinumab in chronic plaque psoriasisRani Soenen, Zhigang Wang, Lynda Grine, et al.
Journal of Immunological Methods|August 19, 2009
Development and evaluation of monoclonal antibodies as probes to assess the differences between two tomato pectin methylesterase isoenzymesEvelien Vandevenne, Sandy Van Buggenhout, Thomas Duvetter, et al.
Journal of Pharmaceutical and Biomedical Analysis|July 3, 2020
Development and validation of immunoassays for monitoring of guselkumab and anti-guselkumab antibodies in patients with moderate-to-severe psoriasisNathalie Van den Berghe, Aurélie Truffot, Miet Peeters, et al.
Research and Practice in Thrombosis and Haemostasis|July 22, 2022
Novel ELISA for the specific detection of protease NEXIN-1 in human biological samplesLaurence Venisse, Déborah François, Célina Madjène, et al.
Pageof 2